INTRODUCTION
Pseudomalignant myositis ossificans is an idiopathic, self-limiting, benign connective tissue disorder. 1 Its presenting features can closely resemble those of a soft-tissue sarcoma, with the resultant potential for inappropriate initial management. We report such a disease in a young man and discuss pertinent features in the differential diagnosis of this condition.
CASE REPORT
In March 2002, a 22-year-old man presented to the Kovai Medical Centre and Hospital in Coimbatore with a lump in the medial aspect of the right thigh. The lump had slowly increased in size over the 5 months since first noticed and had been painful for one month. The patient had no history of injury or systemic symptoms. He was not involved in professional or recreational sports activities. The patient had been treated elsewhere with a course of intravenous antibiotics.
Clinical examination revealed a non-tender, firm, irregular mass in the adductor muscles of the right thigh. The patient had full range of movement of the hip and knee. Radiography showed areas of irregular calcification in the medial aspect of the thigh. No cortical thickening of the femur was seen; periosteal reaction was evident along the medial aspect of the femur. Ultrasound imaging showed a soft-tissue mass with calcification and increased vascularity. Magnetic resonance imaging of the thigh did not contribute any further diagnostic information.
An excision biopsy was performed. The mass excised was firm to hard, measuring 5x5 cm. Gross examination showed a greyish-white lesion, with areas of bluish discolouration. Following an initial histopathological examination, the tumour was reported to be a low-grade soft-tissue osteosarcoma. A second opinion confirming the diagnosis of a lowgrade soft-tissue osteosarcoma was obtained from a teaching institute, although one pathologist queried the malignant nature of the tumour. A chemotherapy regimen of cisplatin and actinomycin was commenced, due to concern about the potential for tumour spread. A third opinion was sought from a pathologist specialising in orthopaedic oncology who reported the mass as evidence of myositis ossificans. Chemotherapy was thus temporarily withdrawn. Tissue slides were sent to another pathologist specialising in tumours and malignancies and the specimen was confirmed as pseudomalignant myositis ossificans. This report was taken as final and the chemotherapy regimen was discontinued.
At one-year follow-up, the patient had no evidence of recurrence on repeated radiography and magnetic resonance imaging.
DISCUSSION
The presence of any soft-tissue mass without antecedent trauma raises the possible diagnosis of a sarcomatous lesion. Histopathological examination cannot always readily distinguish a soft tissue osteosarcoma from pseudomalignant myositis ossificans. As a result, radical treatment (for example, amputation) may be contemplated. Pseudomalignant myositis ossificans is a non-aggressive condition and is compatible with long-term survival. Most patients present with this in their 20s or 30s.
Histologically, pseudomalignant myositis ossificans produces osteoid like an osteosarcoma. The proliferating, immature fibroblasts with hyperchromatic nuclei can be thought to be sarcomatous changes (Fig. 1) . The 'zoning phenomenon'-a central layer of cells and a peripheral layer of natural osteoid (Fig. 2) -is the most important feature for differentiating pseudomalignant myositis ossificans from osteosarcoma. Evidence of the zoning phenomenon should be sought and histopathological findings correlated with clinical and radiological findings to avoid misdiagnosis of this condition. Painless and slow progression of the lesion and the absence of early calcification are suggestive of a nonmalignant tumour. 
